1.Methylphenidate increased regional cerebral blood flow in subjects with attention deficit/hyperactivity disorder.
Boong Nyun KIM ; Jae Sung LEE ; Soo Churl CHO ; Dong Soo LEE
Yonsei Medical Journal 2001;42(1):19-29
The regional cerebral blood flow (rCBF) responses to methylphenidate (MPH) treatment were examined in children with attention deficit/hyperactivity disorder (ADHD). Thirty-two male children, diagnosed with ADHD by the DSM-IV diagnostic criteria, other behavioral assessment scales and neuropsychological battery, were studied using 99mTc-HMPAO-single photon emission computed tomography (SPECT). Subjects were studied before and after MPH treatment. First, using an image subtraction method, we obtained a NDR parametric image of each patient and found increased cerebral blood flow in the frontal lobes, caudate nuclei and thalamic areas after treatment. When the changes in SPECT and clinical response were compared, the matching rate, sensitivity and specificity between them were found to be 77.1, 80.0 and 79.2%, respectively. Second, three transaxial brain slices delineating anatomically defined regions of interest (ROI) at 20, 40, and 60mm above the orbitomeatal line (OML) were used, with the average number of counts for each region of interest normalized to the area of the cerebellar maximal uptake. The left and right prefrontal areas, and caudate and thalamic areas showed significant increases in rCBF after MPH treatment. These findings suggested MPH could affect the function of the fronto-striato-thalamic circuit, which is known as the pathophysiologic site of ADHD and could be used to correct the underlying brain dysfunction of ADHD.
Adolescence
;
Attention Deficit Disorder with Hyperactivity/radionuclide imaging
;
Attention Deficit Disorder with Hyperactivity/physiopathology
;
Attention Deficit Disorder with Hyperactivity/drug therapy*
;
Central Nervous System Stimulants/pharmacology*
;
Cerebrovascular Circulation/drug effects*
;
Child
;
Female
;
Human
;
Male
;
Methylphenidate/therapeutic use
;
Methylphenidate/pharmacology*
;
Tomography, Emission-Computed, Single-Photon
2.The Neuroradiological Findings of Children with Developmental Language Disorder.
Sang Hee IM ; Eun Sook PARK ; Deog Young KIM ; Dong Ho SONG ; Jong Doo LEE
Yonsei Medical Journal 2007;48(3):405-411
PURPOSE: To investigate the general characteristics of glucose metabolism distribution and the functional deficit in the brain of children with developmental language delay (DLD), we compared functional neuroradiological studies such as positron emission tomography (PET) of a patient group of DLD children and a control group of attention- deficit hyperactivity disorder (ADHD) children. PATIENTS AND METHODS: Seventeen DLD children and 10 ADHD children under 10 years of age were recruited and divided into separate groups consisting of children less than 5 years of age or between 5 and 10 years of age. The PET findings of 4 DLD children and 6 control children whose ages ranged from 5 to 10 years were compared by Statistical Parametric Mapping (SPM) analysis. RESULTS: All of the DLD children revealed grossly normal findings in brain MRIs, however, 87.5% of them showed grossly abnormal findings in their PET studies. Abnormal findings were most frequent in the thalamus. The patient group showed significantly decreased glucose metabolism in both frontal, temporal and right parietal areas (p < 0.005) and significantly increased metabolism in both occipital areas (p < 0.05) as compared to the control group. CONCLUSION: This study reveals that DLD children may show abnormal findings on functional neuroradiological studies, even though structural neuroradiological studies such as a brain MRI do not show any abnormal findings. Frequent abnormal findings on functional neuroradiological studies of DLD children, especially in the subcortical area, suggests that further research with quantitative assessments of functional neuroradiological studies recruiting more DLD children and age-matched normal controls could be helpful for understanding the pathophysiology of DLD and other disorders confined to the developmental disorder spectrum.
Attention Deficit Disorder with Hyperactivity/metabolism/*pathology
;
Basal Ganglia/abnormalities/metabolism/radionuclide imaging
;
Brain/*abnormalities/metabolism/radionuclide imaging
;
Caudate Nucleus/abnormalities/metabolism/radionuclide imaging
;
Cerebellum/abnormalities/metabolism/radionuclide imaging
;
Child
;
Child, Preschool
;
Glucose/metabolism
;
Humans
;
Language Development Disorders/metabolism/*pathology
;
Magnetic Resonance Imaging
;
Positron-Emission Tomography
;
Thalamus/abnormalities/metabolism/radionuclide imaging